INS and Parkinson disease: Additionally, a placebo-controlled study demonstrated that intranasal insulin improves cognitive and motor function in PD patients without significantly affecting blood glucose levels, further indicating that these benefits may occur independently of glucose regulation (Novak et al. 2019).